Back to Search Start Over

[Postoperative Management of Refractory Pleural Effusion in a Patient with Esophageal Cancer Accompanied by Cirrhosis]

Authors :
Yu, Xiaolin
Shigeru, Takeda
Yusaku, Watanabe
Michihisa, Iida
Tsunenori, Yamamoto
Chiyo, Nakashima
Mitsuo, Nishiyama
Hiroto, Matsui
Yoshitaro, Shindo
Yukio, Tokumitsu
Shinobu, Tomochika
Shin, Yoshida
Nobuaki, Suzuki
Tatsuya, Ioka
Hiroaki, Nagano
Source :
Gan to kagaku ryoho. Cancerchemotherapy. 48(13)
Publication Year :
2022

Abstract

This study reports a case of a 61-year-old man with a chief complaint of anemia. The patient was diagnosed with esophageal cancer(Stage Ⅰ). Preoperative examination revealed alcoholic liver cirrhosis(Child-Pugh A, liver damage B). After a period of abstinence to improve liver function, minimally invasive esophagectomy, retrosternal reconstruction with a gastric tube, and two-field lymph node dissection were performed. The thoracic duct was preserved during the operation. Post- surgery, the bill pleural effusion was increased. Drainage was initiated using thoracentesis with frosemide, spironolactone, and tolvaptan. On post-operating day(POD)35, the patient was discharged; however, right pleural effusion continued to increase. Therefore, cell-free and concentrated reinfusion therapy for right pleural effusion was performed on POD 56. After the treatment, the pleural effusion was well-controlled with 20 mg of frosemide. This case suggested that cell-free and concentrated pleural effusion reinfusion therapy contributed to the management of refractory pleural effusion in patients with esophageal cancer accompanied by cirrhosis.

Details

ISSN :
03850684
Volume :
48
Issue :
13
Database :
OpenAIRE
Journal :
Gan to kagaku ryoho. Cancerchemotherapy
Accession number :
edsair.pmid..........a9d45bbd73dd1a56acfa7015a810ce5d